Diagnostic Approach for Cardiomegaly

Initial Diagnostic Workup

The American College of Cardiology recommends that when cardiomegaly is identified on chest X-ray, a transthoracic echocardiogram should be ordered as the essential first-line confirmatory test, followed by an ECG and natriuretic peptide levels, to direct treatment toward the specific underlying cardiac pathology identified 1, 2
Transthoracic echocardiography is mandatory to verify true cardiomegaly, measure ejection fraction, identify the mechanism of cardiac dysfunction, assess valvular structure and function, evaluate left atrial size, measure right ventricular function, and estimate pulmonary artery pressures 1, 2
A single echocardiogram will differentiate between heart failure with reduced ejection fraction, heart failure with preserved ejection fraction, and non-cardiac causes of the enlarged cardiac silhouette 2
Obtain a 12-lead ECG to identify rhythm disturbances, conduction abnormalities, evidence of prior myocardial infarction, left ventricular hypertrophy, or active ischemia 2
Draw natriuretic peptides which have reasonable negative predictive value for excluding heart failure 2
Order Holter monitoring if cardiac sarcoidosis is suspected (>100 ventricular ectopic beats in 24 hours suggests this diagnosis) 3

Cardiac MRI with late gadolinium enhancement is indicated when echocardiography is inconclusive for diagnosis, when additional anatomic information is needed, or when evaluating for infiltrative diseases like cardiac sarcoidosis, amyloidosis, or Fabry disease 3, 4
For cardiac sarcoidosis specifically, early enhancement on T2-weighted gadolinium images suggests active inflammation and edema, while late enhancement suggests fibrotic changes and scarring, with preferential involvement of basal septal and lateral wall segments 3

Assess for orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, fatigue, and establish baseline exercise tolerance 2
Identify cardiovascular risk factors including hypertension, coronary artery disease, diabetes, and valvular disease 2
Evaluate for symptoms suggesting specific etiologies: chronic cough may be the primary presenting symptom of heart failure with pulmonary venous congestion 2
Assess jugular venous pressure for elevated right heart filling pressures 2
Auscultate for a third heart sound indicating elevated left ventricular filling pressure, fourth heart sound, and cardiac murmurs 2

Complete blood count, renal function, electrolytes, and thyroid function tests are essential for heart failure assessment and to rule out other causes 1
Low sodium and elevated creatinine are adverse prognostic factors in heart failure 2

Initiate guideline-directed medical therapy immediately with ACE inhibitors or ARBs, beta-blockers, mineralocorticoid receptor antagonists, SGLT2 inhibitors, and diuretics for volume management in patients with reduced ejection fraction 1, 2, 3
Focus treatment on underlying conditions, such as aggressive blood pressure control for hypertension, rate or rhythm control for atrial fibrillation, and management of volume overload with diuretics in patients with preserved ejection fraction 1, 2
Consider surgical or percutaneous intervention for mitral regurgitation or stenosis, and valve repair or replacement for patients with hemodynamically significant valvular disease 1, 2
Revascularization is recommended for patients with ischemic cardiomyopathy 1
For cardiac sarcoidosis: Corticosteroids are commonly initiated at high dose and tapered slowly over months if clinical and imaging features remain stable or improve 3

Regular clinical assessment with attention to symptoms of heart failure 1
Serial echocardiography to monitor cardiac size and function 1
Adjustment of medical therapy based on clinical response 1
Follow-up intervals depend on specific lesions and residual abnormalities for patients with congenital heart disease 1